Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Colesevelam hydrochloride
Drug ID BADD_D00519
Description Colesevelam is a bile acid sequestrant. Colesevelam is used with exercise and diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in the blood. It works by binding bile acids in the intestine. Bile acids are made when cholesterol is broken down in the body. Removing these bile acids helps to lower blood cholesterol.
Indications and Usage For use, alone or in combination with an HMG-CoA reductase inhibitor, as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in patients with primary hypercholesterolemia (Fredrickson Type IIa).
Marketing Status Prescription; Discontinued
ATC Code C10AC04
DrugBank ID DB00930
KEGG ID D03582
MeSH ID D000069472
PubChem ID 60208760
TTD Drug ID D01YVT
NDC Product Code 65597-902; 51660-995; 69452-158; 75834-152; 59651-080; 27808-190; 45941-3050; 0115-1320; 42291-147; 63629-2446; 66499-0022; 67877-523; 51407-336; 63629-8860; 60687-621; 65597-701; 68462-433; 76339-153; 51660-996; 51407-159; 60687-385; 43598-230; 66406-0106; 68462-620
Synonyms Colesevelam Hydrochloride | Hydrochloride, Colesevelam | Colesevelam HCl | HCl, Colesevelam | CholestaGel | Welchol | Colesevelam | GT 31104 | 31104, GT | GT-31104 | GT31-104 | GT31 104 | GT31104
Chemical Information
Molecular Formula C31H67Cl3N4O
CAS Registry Number 182815-44-7
SMILES [H+].CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.[Cl-].[Cl-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Influenza22.07.02.001; 11.05.03.001--Not Available
Injury12.01.08.004--Not Available
Intestinal obstruction07.13.01.002--Not Available
Myalgia15.05.02.001--
Myocardial infarction24.04.04.009; 02.02.02.007--
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
Nausea07.01.07.001--
Nervous system disorder17.02.10.001--Not Available
Oesophageal obstruction07.13.02.002--
Pain08.01.08.004--
Pancreatitis07.18.01.001--
Pancreatitis acute07.18.01.002--Not Available
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Rash23.03.13.001--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Seizure17.12.03.001--
Sinusitis11.01.13.005; 22.07.03.007--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Vomiting07.01.07.003--
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Transaminases increased13.03.01.015--Not Available
Faecaloma07.01.03.004--Not Available
Faecalith07.01.03.007--Not Available
Connective tissue disorder15.06.01.006--Not Available
The 2th Page    First    Pre   2    Total 2 Pages